TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 NOK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
2,930,547
|
2,056,686
|
1,315,259 |
| Earnings before taxes |
984,512
|
504,781
|
261,589 |
| Total assets |
4,212,230
|
3,318,157
|
1,561,234 |
| Current assets |
2,833,193
|
2,277,211
|
825,127 |
| Current liabilities |
2,524,971
|
1,883,945
|
935,995 |
| Equity capital |
849,759
|
480,120
|
284,061 |
| - share capital |
57,474
|
60,571
|
56,581 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
20.2%
|
14.5%
|
18.2% |
| Turnover per employee |
8,373
|
5,876
|
3,758 |
| Profit as a percentage of turnover |
33.6%
|
24.5%
|
19.9% |
| Return on assets (ROA) | |||
| Current ratio |
112.2%
|
120.9%
|
88.2% |
| Return on equity (ROE) |
115.9%
|
105.1%
|
92.1% |
| Change turnover |
979,019
|
648,687
|
400,760 |
| Change turnover % |
50%
|
46%
|
44% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.